Globe Newswire (Tue, 24-Feb 8:30 AM ET)
Market Chameleon (Thu, 29-Jan 5:29 AM ET)
Market Chameleon (Wed, 28-Jan 4:53 AM ET)
Globe Newswire (Wed, 28-Jan 9:00 AM ET)
ENvue Medical Appoints Industry Veteran Marc Waldman as Vice President, Commercial
Globe Newswire (Wed, 21-Jan 8:30 AM ET)
Globe Newswire (Wed, 14-Jan 8:30 AM ET)
Globe Newswire (Fri, 9-Jan 9:01 AM ET)
ENvue Medical to Ring the Nasdaq Opening Bell on Wednesday, January 14th, 2026
Globe Newswire (Thu, 8-Jan 10:02 AM ET)
ENvue Medical, Formerly NanoVibronix, UroShield Kit Secures Reimbursement in the UK
Globe Newswire (Thu, 18-Dec 12:30 PM ET)
ENvue Medical's UroShield Kit Secures Reimbursement in the UK
Globe Newswire (Thu, 18-Dec 9:00 AM ET)
ENvue Medical Inc develops medical devices for enhanced navigation in clinical procedures. The company provides personalized navigation technology to assist clinicians in placing feeding tubes safely and efficiently. Its ENvue system uses smart feeding tubes with sensors, body mapping, and continuous visual guidance to confirm accurate positioning and reduce complications like lung misplacement. It targets safety in ICUs and hospitals while exploring applications in vascular access.
Envue Medical trades on the NASDAQ stock market under the symbol FEED.
As of February 27, 2026, FEED stock price declined to $2.08 with 188,176 million shares trading.
FEED has a market cap of $2.26 million. This is considered a Sub-Micro Cap stock.
The top ETF exchange traded funds that FEED belongs to (by Net Assets): VXF.
FEED support price is $1.95 and resistance is $2.58 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that FEED shares will trade within this expected range on the day.
